A trading company with immense expertise in supplying & trading of Pharmaceutical equipment/machines is looking for suppliers of Rivaroxaban (5kg) API. Interested suppliers must support this enquiry with a GMP Certificate and CoA.

Reply

Comments :

gm@probitypvt.com

Hi
can you get in touch to take this forward?

12:35,  15 Apr 2019
Reply

thinkchem@aliyun.com

Hi
We can offer chinese source Rivaroxaban, Please kindly contact us

06:47,  17 Apr 2019
Reply

thinkchem@aliyun.com

Hi
We can offer chinese source Rivaroxaban, Please kindly contact us

06:47,  17 Apr 2019
Reply

marketing@baschamlifesciences.com

Greetings from Bascham Life Sciences

We are pleased to inform you that we can support this requirement. Kindly share your contact details on our email to proceed further

Regards
Bascham Team, India

00:28,  20 Apr 2019
Reply

hostrinlifesciences@gmail.com




Dear Friend,

Greetings from Hostrin Life sciences!!!

We have been supporting for the following services.

1.We do support DMF's for API's, Tech transfer support and Registration of Dossiers in MOH /MHRA/EMEA/USA support in CTD, ACTD, eCTD and ANDA's formats with 5 modules including BA and BE studies /Clinical studies/trials for API's & Formulation's in Pharmaceutical, Ayurveda, Biotech, Biosimilar, vitamins , Peptides and recently Transdermal patches too.

2. Impurity's & Reference standards support for API's

3. Services for IPR & Regulatory compliance

4. Services for QMS & supporting of QBD - SIGMA TECH Software version 3.1 for DOE, Robustness for the R&D in Pharma, Biotech, Biosimilars companies who are willing to enter into the Regulatory market which is mandatory to show for FDA.

5. Custom synthesis & Contract manufacturing services

6. Synthetic Resins technologies support

Pls don't hesitate to send your enquiry's. For your reference please go through our website www.hostringlobal.com

Best Regards,
Andrew P
CEO & Managing Director
Hostrin Life sciences
hostrinlifesciences@gmail.com
andrew@hostringlobal.com
Mobile/
WhatsApp: +91 9949930343

17:27,  18 May 2019
Reply